A new antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses, a multi-institutional team of investigators reports this week in Science Translational Medicine. The findings support further development of the drug candidate for treating and preventing current coronavirus infections and potential future epidemic outbreaks.
Coronaviruses are a genetically diverse family of viruses that infect birds and mammals, with most coronavirus strains limited to infecting only certain hosts. Human coronaviruses, for example, cause up to 30 percent of common colds.
In the last 15 years, however, coronaviruses have demonstrated their ability to jump into new species. Zoonotic (animal) coronaviruses have infected humans, causing severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), severe diseases with high mortality rates ranging from 10 percent for SARS to 40 percent for MERS. The MERS-coronavirus continues to cause new infections in the Middle East.
“There’s a real concern that the MERS coronavirus could escape broadly when millions of people visit Saudi Arabia for the Hajj,” said Mark Denison, M.D., Craig-Weaver Professor of Pediatrics and professor of Pathology, Microbiology and Immunology at Vanderbilt University School of Medicine.
But to date, there has been no effective antiviral drug for any known coronavirus, Denison noted.
Denison and his team at Vanderbilt have studied the basic biology of coronaviruses for more than 20 years. In an effort to find chemical tools that would allow them to probe viral replication, graduate student Brett Case screened a series of compounds selected and provided by Gilead Sciences.
Case demonstrated that one of the compounds was highly active against coronaviruses in cultured cells. The finding was a surprise, Denison said, because compounds in the same class (nucleoside analogs) have normally failed to inhibit coronavirus replication.
The compound, called GS-5734, is currently in clinical development for treatment of Ebola virus disease.
Denison’s longtime collaborator Ralph Baric, Ph.D., at the University of North Carolina and his team demonstrated that GS-5734 inhibits SARS-coronavirus and MERS-coronavirus replication in multiple in vitro systems, including cultures of primary human airway epithelial cells, which are the cells infected by respiratory coronaviruses.
The researchers also showed that GS-5734 was effective against a circulating human coronavirus, bat coronaviruses, and bat coronaviruses that are considered “prepandemic” because they can infect cultured human cells.
Using a mouse model of SARS, the investigators demonstrated that both prophylactic (before infection) and early therapeutic (soon after infection) administration of GS-5734 reduced viral load in the lungs and improved respiratory functions.
“This compound shows broad activity against a variety of human and animal coronaviruses and represents an exciting potential therapeutic for a family of viruses prone to emergence from animal reservoirs,” Denison said.
Denison and his team at Vanderbilt will continue to use the compound “as a probe to try to understand the biology of the virus, how and why this drug works, and to identify new targets for inhibiting coronaviruses,” he said.
“This is an exciting example of how pursuing fundamental research to understand the mechanisms of virus replication and pathogenesis can lead to an important compound with therapeutic potential.”
The Latest on: Coronaviruses
[google_news title=”” keyword=”coronaviruses” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- COVID-19 cases are again on the rise, so how long should you self-isolate now there are no requirements?on November 28, 2023 at 10:22 am
After NSW Premier Chris Minns contracted the virus this week, he strongly recommended people stay at home until their COVID symptoms subside. Here's what the experts say.
- Covid-19 vaccines may have prevented thousands of premature births, study suggestson November 28, 2023 at 8:18 am
Covid-19 vaccinations may have prevented thousands of premature births, new research suggests. Mothers infected with the Covid virus were significantly more at risk of delivering early in the ...
- New COVID-19 variant is spreading, poses 'low' public health riskon November 28, 2023 at 6:50 am
The prevalence of a highly mutated COVID-19 variant has tripled in the past two weeks, new government data shows.
- Did California or Florida handle COVID-19 better? The answer is complicatedon November 28, 2023 at 6:37 am
In terms of the overall death rate, Florida tops California, but there is a lot of nuance that’s not clear from that metric alone.
- Covid-19 boosters and flu jabs availableon November 28, 2023 at 4:27 am
People who are eligible for a Covid-19 booster jab can receive one at some of Jersey's parish halls from Tuesday. The vaccination team will be holding a clinic in St Peter until 15:30 GMT on Tuesday.
- Thousands of preterm births likely prevented by COVID-19 vaccines, study findson November 28, 2023 at 2:30 am
Yet a new study published in the Proceedings of the National Academy of Sciences adds to ongoing scientific evidence that there are benefits to getting vaccinated against the coronavirus while ...
- Answer Woman: With COVID-19 on the rise where are Asheville's outdoor heated patios?on November 28, 2023 at 2:13 am
An Asheville Citizen Times reader asks for which restaurants have heated, outdoor, covered patios this winter.
- COVID-19 hospitalizations jump in Milwaukee County by over 50% in last week, county official sayson November 27, 2023 at 1:59 pm
About 99 people in Milwaukee County are hospitalized with COVID-19, a jump of more than 50% from a week ago, said Dr. Ben Weston, a county official.
- COVID-19 rapid tests now available without appointment at some N.B. siteson November 27, 2023 at 1:15 pm
Free COVID-19 rapid test kits are a bit easier to acquire in New Brunswick now that the Department of Health has dropped the requirement for pickup appointments at some locations.
- EXCLUSIVE: Chinese scientists find a NEW bat coronavirus linked to pangolins that has same freak mutation as Covid - and some experts say it shoots down the lab leak theoryon November 25, 2023 at 8:05 am
Researchers in China have found another bat coronavirus that possesses a furin cleavage site - the part that made Covid-19 so good at infecting people.
via Google News and Bing News